Modifications to Guidance Regarding ACA Tax on Prescription Drugs

Notice 2011-9 modifies and supersedes Notice 2010-71regarding the Affordable Care Act’s excise tax on certain manufacturers of prescription drugs.

Document Excerpt

This notice modifies, restates, and supersedes Notice 2010-71, 2010-50 I.R.B.822, which provides guidance on the annual fee imposed by section 9008 of the Affordable Care Act on certain manufacturers and importers (covered entities) of branded prescription drugs. The modifications reflected in this notice affect Part I -Information Requested from Covered Entities, Part II – Preliminary Fee Calculation for 2011, and Part III – Request for Comments. All other sections of Notice 2010-71 are restated in this notice without change.




About Us

Benefits Forward is a news site for professionals in the field of employee benefits. Our goal is to provide the latest information about the benefits field and to host a community discussion regarding related issues.

Seminars, Conferences & Other Events

  • Sorry, there are no articles in this category.

Need Help Correcting Plan Errors?

Contact us for either consultation on how you can Self Correct or to propose cost effective correction methods using VCP. Or contact us to submit under VCP on your behalf or on behalf of your client. Contact us by email.